DrugDrug NameDrug Indication
DB04887BrecanavirFor the treatment of HIV-1 infection in combination with other antiretroviral agents.
DB04961TroxacitabineInvestigated for use/treatment in leukemia (myeloid).
DB05423ORG-34517Investigated for use/treatment in depression.
DB06619AmdoxovirInvestigated for use/treatment in HIV infection and acquired immune deficiency syndrome (AIDS) and aids-related infections.
DB06814ProtokylolNot Available
DB09118StiripentolIndicated for use in conjunction with clobazam and valproate as adjunctive therapy of refractory generalized tonic-clonic seizures in patients with severe myoclonic epilepsy in infancy (SMEI, Dravet’s syndrome) whose seizures are not adequately controlled with clobazam and valproate.
DB09280LumacaftorWhen given in combination with [DB08820] as the fixed dose combination product Orkambi, lumacaftor is indicated for the treatment of cystic fibrosis (CF) in patients age 6 years and older who are homozygous for the F508del mutation in the CFTR gene [FDA Label].
DB09350Piperonyl butoxideFor the treatment of head, pubic (crab), and body lice.
DB11805SaracatinibNot Available
DB11892PrulifloxacinNot Available
DB12582PiperineNot Available
DB12638PU-H71Not Available
DB13768DomiodolNot Available
DB13927anle138bNot Available